CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -41.7% | 12,013 | -7.2% | 0.00% | – |
| Q2 2023 | $48 | +118.2% | 12,946 | +114.7% | 0.00% | – |
| Q1 2023 | $22 | +29.4% | 6,029 | 0.0% | 0.00% | – |
| Q4 2022 | $17 | -99.9% | 6,029 | -2.6% | 0.00% | – |
| Q3 2022 | $14,000 | -22.2% | 6,188 | -14.2% | 0.00% | – |
| Q2 2022 | $18,000 | -70.0% | 7,214 | -40.9% | 0.00% | – |
| Q1 2022 | $60,000 | -94.0% | 12,211 | -86.3% | 0.00% | – |
| Q4 2021 | $1,006,000 | +249.3% | 88,842 | +349.0% | 0.00% | – |
| Q3 2021 | $288,000 | +336.4% | 19,785 | +251.3% | 0.00% | – |
| Q2 2021 | $66,000 | -78.1% | 5,632 | -77.2% | 0.00% | – |
| Q1 2021 | $302,000 | +81.9% | 24,730 | +85.4% | 0.00% | – |
| Q4 2020 | $166,000 | -42.0% | 13,342 | -29.9% | 0.00% | – |
| Q3 2020 | $286,000 | -24.9% | 19,028 | +22.4% | 0.00% | – |
| Q2 2020 | $381,000 | +305.3% | 15,547 | +133.0% | 0.00% | – |
| Q1 2020 | $94,000 | -70.3% | 6,672 | -66.6% | 0.00% | – |
| Q4 2019 | $317,000 | +164.2% | 19,957 | +40.2% | 0.00% | – |
| Q3 2019 | $120,000 | +14.3% | 14,235 | +22.4% | 0.00% | – |
| Q2 2019 | $105,000 | +162.5% | 11,632 | +126.5% | 0.00% | – |
| Q1 2019 | $40,000 | -33.3% | 5,136 | -22.5% | 0.00% | – |
| Q3 2018 | $60,000 | +300.0% | 6,628 | +412.2% | 0.00% | – |
| Q2 2018 | $15,000 | -42.3% | 1,294 | -29.8% | 0.00% | – |
| Q1 2018 | $26,000 | – | 1,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 820,000 | $11,636,000 | 12.56% |
| Prosight Management, LP | 552,060 | $7,834,000 | 3.66% |
| Nantahala Capital Management | 2,503,840 | $35,529,000 | 1.33% |
| MANGROVE PARTNERS IM, LLC | 601,398 | $8,534,000 | 1.18% |
| Voss Capital, LLC | 88,670 | $749,000 | 1.00% |
| Slate Path Capital LP | 870,694 | $12,355,000 | 0.95% |
| Avoro Capital Advisors LLC | 1,870,000 | $26,535,000 | 0.90% |
| Bleichroeder LP | 165,000 | $2,341,000 | 0.61% |
| 683 Capital Management, LLC | 640,000 | $9,082,000 | 0.54% |
| PA Capital LLC | 40,706 | $578,000 | 0.51% |